Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

11 Sept 2019

Abstract excerpt

PURPOSE To develop a risk score for patients with advanced systemic mastocytosis (AdvSM) that integrates clinical and mutation characteristics. PATIENTS AND METHODS The study included 383 patients with AdvSM from the German Registry on Disorders of Eosinophils and Mast Cells (training set; n = 231) and several centers for mastocytosis in the United States and Europe, all within the European Competence Network on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma and respiratory diseases
Share to Mast cells and histamine
Share to Veterinary Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31509472
DOI: 10.1200/jco.19.00640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MARS: Mutation-Adjusted Risk Score for Advanced Systemic MastocytosisPMID 31509472Read ↗

Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.Semantic proximity Read ↗

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.Semantic proximity Read ↗

Leukocytosis, Monocytosis, and Eosinophilia in Systemic Mastocytosis: Analysis of Phenotype, Genetics and Prognosis in 596 Patients From the GREM Registry.Semantic proximity Read ↗

The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm.Semantic proximity Read ↗

Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis.Semantic proximity Read ↗

Impact of somatic and germline mutations on the outcome of systemic mastocytosisSemantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.Semantic proximity Read ↗

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic MastocytosisSemantic proximity Read ↗

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.